BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$77.89
+5.21%Leverage
- Debt / equity
- -1.50x
- Net debt / equity
- -0.58x
- Debt / assets
- 1.15x
- Debt / EBITDA
- -5.66x
- Net debt / EBITDA
- -2.18x
Liquidity & coverage
- Current ratio
- 2.09x
- Quick ratio
- 2.03x
- Cash ratio
- 1.57x
- Interest coverage
- -3.07x
- EBITDA / interest
- -3.30x
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- -0.15x
- Cash flow / debt
- -0.15x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026